| scholarly article | Q13442814 |
| P2093 | author name string | Martin Himly | |
| Albert Duschl | |||
| Mark Geppert | |||
| Richard Weiss | |||
| Litty Johnson | |||
| Evgeniia Korotchenko | |||
| Robert Mills-Goodlet | |||
| Sara Michelini | |||
| Anna I Joubert | |||
| Jutta Horejs-Höck | |||
| P2860 | cites work | Animal allergens and their presence in the environment | Q21131165 |
| IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 | ||
| Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response | Q24613860 | ||
| Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization | Q24631966 | ||
| Exposure to multiple indoor allergens in US homes and its relationship to asthma | Q24657632 | ||
| Climate Change and Air Pollution: Effects on Respiratory Allergy | Q26743372 | ||
| Pollen Allergens for Molecular Diagnosis | Q26752809 | ||
| A Review of the Effects of Major Atmospheric Pollutants on Pollen Grains, Pollen Content, and Allergenicity | Q26773069 | ||
| Allergens, sources, particles, and molecules: Why do we make IgE responses? | Q26782482 | ||
| Vaccine applications of flow cytometry | Q27004341 | ||
| Acute respiratory effects of particulate air pollution | Q28246321 | ||
| Protection from childhood asthma and allergy in Alpine farm environments-the GABRIEL Advanced Studies | Q28265303 | ||
| Immunological mechanisms of allergen-specific immunotherapy | Q28265326 | ||
| A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells | Q91294809 | ||
| Keeping Allergen Names Clear and Defined | Q91670571 | ||
| Birch pollen allergy in Europe | Q92096743 | ||
| Fish-derived low molecular weight components modify bronchial epithelial barrier properties and release of pro-inflammatory cytokines | Q92132407 | ||
| Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy | Q92230033 | ||
| Evaluation of size and dose effects of rChe a 3 allergen loaded PLGA nanoparticles on modulation of Th2 immune responses by sublingual immunotherapy in mouse model of rhinitis allergic | Q92562801 | ||
| Perception and practice of sublingual immunotherapy among practicing allergists in the United States: A follow-up survey | Q92850199 | ||
| Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model | Q92965914 | ||
| Fine particulate matter (PM2.5) enhances airway hyperresponsiveness (AHR) by inducing necroptosis in BALB/c mice | Q93101151 | ||
| Aluminum compounds as vaccine adjuvants | Q95787646 | ||
| A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles should receive special attention for possible adverse health outcomes in human subjects | Q28385963 | ||
| Adverse effect of nano-silicon dioxide on lung function of rats with or without ovalbumin immunization | Q28386321 | ||
| Aerosolized Silver Nanoparticles in the Rat Lung and Pulmonary Responses over Time | Q28397182 | ||
| Notch directly regulates Gata3 expression during T helper 2 cell differentiation | Q28594834 | ||
| Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch | Q28594879 | ||
| The allergy epidemics: 1870-2010. | Q28608569 | ||
| Allergic diseases and air pollution | Q28686893 | ||
| Cardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped Nanosilver | Q29248143 | ||
| Exposure to Indoor Allergens in Different Residential Settings and Its Influence on IgE Sensitization in a Geographically Confined Austrian Cohort | Q29248310 | ||
| Pulmonary Toxicity of Instilled Silver Nanoparticles: Influence of Size, Coating and Rat Strain | Q29248671 | ||
| Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
| Fine particulate matter (PM2.5) enhances allergic sensitization in BALB/c mice | Q29960427 | ||
| EAACI Molecular Allergology User's Guide | Q30276634 | ||
| Airborne dust mite allergens: comparison of group II allergens with group I mite allergen and cat-allergen Fel d I. | Q30443447 | ||
| Allergens and their role in the allergic immune response | Q30453700 | ||
| A multicenter, randomized, parallel-group trial assessing compliance, tolerability, safety, and efficacy to treatment with grass allergy tablets in 261 patients with grass pollen rhinoconjunctivitis | Q30472704 | ||
| House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells | Q30492200 | ||
| In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. | Q30671184 | ||
| High environmental ozone levels lead to enhanced allergenicity of birch pollen | Q30701704 | ||
| Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. | Q31134669 | ||
| How is the indoor environment related to asthma?: literature review | Q33224238 | ||
| Allergen Avoidance in Allergic Asthma | Q33653658 | ||
| Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation | Q33702318 | ||
| Allergic diseases and asthma: a global public health concern and a call to action | Q33712275 | ||
| Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms | Q33758296 | ||
| Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells | Q33949038 | ||
| Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System | Q34097796 | ||
| Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen | Q34161524 | ||
| Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles | Q34177556 | ||
| Transcutaneous vaccination via laser microporation | Q34323166 | ||
| Synthesis and surface functionalization of silica nanoparticles for nanomedicine | Q34417407 | ||
| Environmental tobacco smoke exposure and risk of allergic sensitisation in children: a systematic review and meta-analysis | Q34426257 | ||
| Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere | Q34448304 | ||
| Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo | Q34450442 | ||
| Immune mechanisms of allergen-specific sublingual immunotherapy | Q34484071 | ||
| Aspirin may do wonders by the induction of immunological self-tolerance against autoimmune atherosclerosis. | Q44770486 | ||
| Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity | Q44906742 | ||
| Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba | Q45222536 | ||
| Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults | Q45416013 | ||
| Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. | Q45956342 | ||
| Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils | Q46042924 | ||
| Local Administration of Gold Nanoparticles Prevents Pivotal Pathological Changes in Murine Models of Atopic Asthma | Q46672248 | ||
| Diesel exhaust particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial barrier. | Q46696639 | ||
| Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties | Q46697380 | ||
| Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes | Q46737041 | ||
| Inhalation of concentrated PM2.5 from Mexico City acts as an adjuvant in a guinea pig model of allergic asthma | Q46908094 | ||
| Diesel exhaust particle exposure increases severity of allergic asthma in young mice. | Q46979096 | ||
| Tackling Bet v 1 and associated food allergies with a single hybrid protein. | Q47095653 | ||
| Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis | Q47118742 | ||
| Unbiased Quantitative Proteomics Reveals a Crucial Role of the Allergen Context for the Activation of Human Dendritic Cells. | Q47124635 | ||
| Importance of indoor dust biological ultrafine particles in the pathogenesis of chronic inflammatory lung diseases | Q47135156 | ||
| Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy | Q47152622 | ||
| Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: results from the National Survey of Lead and Allergens in Housing. | Q47229747 | ||
| PLGA nanoparticles loaded with beta-lactoglobulin-derived peptides modulate mucosal immunity and may facilitate cow's milk allergy prevention. | Q47593335 | ||
| Applications and mechanisms of immunotherapy in allergic rhinitis and asthma | Q47653403 | ||
| Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy | Q47971531 | ||
| Local Effects on Airway Inflammation and Systemic Uptake of 5 nm PEGylated and Citrated Gold Nanoparticles in Asthmatic Mice | Q48012996 | ||
| Loss of work productivity due to illness and medical treatment | Q48738131 | ||
| A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients | Q49073680 | ||
| Chemical characteristics and mutagenic activity of PM10 in Torino, a northern Italian city | Q50069470 | ||
| Skin-resident antigen-presenting cells: instruction manual for vaccine development | Q38117141 | ||
| Immunotherapy: what lies beyond | Q38192150 | ||
| A review on the human health impact of airborne particulate matter. | Q38277979 | ||
| Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation | Q38283789 | ||
| The influence of childhood traffic-related air pollution exposure on asthma, allergy and sensitization: a systematic review and a meta-analysis of birth cohort studies. | Q38286279 | ||
| Allergy and asthma: Effects of the exposure to particulate matter and biological allergens. | Q38527614 | ||
| OX40, OX40L and Autoimmunity: a Comprehensive Review. | Q38555213 | ||
| Serological IgE Analyses in the Diagnostic Algorithm for Allergic Disease | Q38629339 | ||
| Interactive effects of specific fine particulate matter compositions and airborne pollen on frequency of clinic visits for pollinosis in Fukuoka, Japan | Q38836570 | ||
| Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. | Q38843395 | ||
| Slow release of ions from internalized silver nanoparticles modifies the epidermal growth factor signaling response | Q38953044 | ||
| Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice | Q39015354 | ||
| Particulate matter composition and respiratory health: the PIAMA Birth Cohort study | Q39019978 | ||
| Adjuvants for allergy immunotherapeutics. | Q39151158 | ||
| Immunotherapy for allergic rhinitis. | Q39260807 | ||
| No further increase in asthma, hay fever and atopic sensitisation in adolescents living in Switzerland | Q39680945 | ||
| Macrophagic myofasciitis: characterization and pathophysiology | Q39776376 | ||
| Respiratory effects of exposure to diesel traffic in persons with asthma | Q39824368 | ||
| Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. | Q39867531 | ||
| Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy. | Q39984129 | ||
| Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys | Q40162227 | ||
| Environmental pollution and allergy: historical aspects. | Q40203817 | ||
| Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study | Q40309560 | ||
| Subpollen particles are rich carriers of major short ragweed allergens and NADH dehydrogenases: quantitative proteomic and allergomic study | Q40414056 | ||
| Fine particulate matter (PM2.5 ) exposure during a prolonged wildfire period and emergency department visits for asthma | Q40566225 | ||
| Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens | Q40639241 | ||
| Pollen and fungus spore counts. | Q40984374 | ||
| The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. | Q40990833 | ||
| Aerobiologic and clinical aspects of mould allergy in Europe | Q41071505 | ||
| Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to | Q41166399 | ||
| Learning impairment and allergic rhinitis. | Q41167167 | ||
| Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization. | Q41175832 | ||
| Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. | Q41214702 | ||
| The role of diesel exhaust particles and their associated polyaromatic hydrocarbons in the induction of allergic airway disease | Q41518439 | ||
| The pathology of asthma | Q41642219 | ||
| Trogocytosis of peptide-MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils. | Q41923469 | ||
| The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity | Q41959710 | ||
| Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines | Q42028648 | ||
| Mechanism of immunopotentiation and safety of aluminum adjuvants. | Q42036323 | ||
| A comparative study of stress-mediated immunological functions with the adjuvanticity of alum | Q42183571 | ||
| Fel d I allergen distribution in cat fur and skin | Q42466910 | ||
| Allergen-Specific Immunotherapy in Asthma | Q42587580 | ||
| Basophils are not the key antigen-presenting cells in allergic patients | Q42591766 | ||
| Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells. | Q43078763 | ||
| Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response. | Q43112818 | ||
| Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells | Q43120646 | ||
| The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey | Q44051269 | ||
| Acute health effects of PM10 pollution on symptomatic and asymptomatic children | Q44236508 | ||
| Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. | Q44293361 | ||
| Combined effects of aerobiological pollutants, chemical pollutants and meteorological conditions on asthma admissions and A & E attendances in Derbyshire UK, 1993-96. | Q44421365 | ||
| Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. | Q54423199 | ||
| Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. | Q55004069 | ||
| A comparative study of the allergens of cat urine, serum, saliva, and pelt. | Q55061310 | ||
| Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation | Q56981050 | ||
| Lung exposure to nanoparticles modulates an asthmatic response in a mouse model | Q57010075 | ||
| Ambient particulate matter enhances the pulmonary allergic immune response to house dust mite in a BALB/c mouse model by augmenting Th2- and Th17-immune responses | Q57102138 | ||
| Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens | Q57216501 | ||
| Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future? | Q57297464 | ||
| Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers | Q57795162 | ||
| The Role of Dust Mites in Allergy | Q57987859 | ||
| Fine Particulate Matter-Induced Exacerbation of Allergic Asthma via Activation of T-cell Immunoglobulin and Mucin Domain 1 | Q58585092 | ||
| Particulate matter and childhood allergic diseases | Q58598810 | ||
| Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis | Q58615148 | ||
| Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis | Q58780229 | ||
| Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action | Q59137099 | ||
| Mechanisms of allergen-specific immunotherapy | Q59271653 | ||
| Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model | Q59356207 | ||
| [Particle size in the smoke produced by six different types of cigarette] | Q59700689 | ||
| Context matters: T2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity | Q60383035 | ||
| Insights in particulate matter-induced allergic airway inflammation: Focus on the epithelium | Q61756869 | ||
| The small airway epithelium as a target for the adverse pulmonary effects of silver nanoparticle inhalation | Q61885096 | ||
| Functional Mesoporous Silica Nanocomposites: Biomedical applications and Biosafety | Q63246447 | ||
| Comparative study of adjuvants for allergen-specific immunotherapy in a murine model | Q64042983 | ||
| Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model | Q64110180 | ||
| Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics | Q70523636 | ||
| Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution | Q73193360 | ||
| Suspended particulate matter in indoor air: adjuvants and allergen carriers | Q73222509 | ||
| Evaluation of impermeable covers for bedding in patients with allergic rhinitis | Q73683115 | ||
| In vivo evidence of free radical formation in the rat lung after exposure to an emission source air pollution particle | Q73827394 | ||
| Laboratory animal allergy | Q74812584 | ||
| Mite allergen (Der p 1) is not only carried on mite feces | Q77807849 | ||
| Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis | Q79189373 | ||
| Prevalence and rate of diagnosis of allergic rhinitis in Europe | Q80936964 | ||
| Pathogenesis of asthma | Q81325145 | ||
| Detection of allergens adsorbed to ambient air particles collected in four European cities | Q82656380 | ||
| Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1 | Q83088516 | ||
| Late-onset anaphylaxis due to poly (γ-glutamic acid) in the soup of commercial cold Chinese noodles in a patient with allergy to fermented soybeans (natto) | Q83692039 | ||
| Local nasal immunotherapy: efficacy of Dermatophagoides farinae-chitosan vaccine in murine asthma | Q83991509 | ||
| Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma | Q84007863 | ||
| Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators | Q84301195 | ||
| Ambient air pollution impairs regulatory T-cell function in asthma | Q85155653 | ||
| Epidemiology of Lung Cancer | Q86906665 | ||
| Curvature-dependent effects of nanotopography on classical immune complement activation | Q88557951 | ||
| Artemisia pollen is the main vector for airborne endotoxin | Q90251624 | ||
| Novel vaccines targeting dendritic cells by coupling allergoids to mannan | Q90468731 | ||
| Association between fire smoke fine particulate matter and asthma-related outcomes: Systematic review and meta-analysis | Q90591352 | ||
| Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial | Q90838026 | ||
| Pulmonary exposure to silver nanoparticles impairs cardiovascular homeostasis: Effects of coating, dose and time | Q91029490 | ||
| Innate Lymphoid Cells: 10 Years On | Q91127104 | ||
| Resolution of allergic asthma | Q91201184 | ||
| Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response | Q37289629 | ||
| High diversity of fungi in air particulate matter | Q37293115 | ||
| Parental smoking and development of allergic sensitization from birth to adolescence | Q37337393 | ||
| Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years | Q37494670 | ||
| IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. | Q37600819 | ||
| A tissue checkpoint regulates type 2 immunity. | Q37611447 | ||
| Recent developments in the role of reactive oxygen species in allergic asthma | Q37636944 | ||
| Respiratory allergies: a general overview of remedies, delivery systems, and the need to progress | Q37679681 | ||
| Signaling by ROS drives inflammasome activation | Q37702144 | ||
| Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. | Q37730878 | ||
| The many paths to asthma: phenotype shaped by innate and adaptive immunity | Q37766451 | ||
| Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. | Q37802050 | ||
| Does outdoor air pollution induce new cases of asthma? Biological plausibility and evidence; a review | Q38016602 | ||
| Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs | Q38049856 | ||
| Adjuvants for allergy vaccines | Q38055323 | ||
| Regulation of innate and adaptive immunity by Notch | Q38105858 | ||
| A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol | Q34548671 | ||
| SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma | Q34577305 | ||
| Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper | Q34754637 | ||
| Indoor particulate matter increases asthma morbidity in children with non-atopic and atopic asthma | Q35054538 | ||
| Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. | Q35091226 | ||
| Regulatory T cells control the development of allergic disease and asthma | Q35298331 | ||
| Increasing prevalence of asthma diagnosis and symptoms in children is confined to mild symptoms | Q35534411 | ||
| Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice. | Q35536686 | ||
| No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001. | Q35537758 | ||
| Indoor air pollution and asthma in children | Q35694330 | ||
| European union regulatory developments for new vaccine adjuvants and delivery systems | Q35802783 | ||
| Preventing carbon nanoparticle-induced lung inflammation reduces antigen-specific sensitization and subsequent allergic reactions in a mouse model | Q35816920 | ||
| Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation | Q35846840 | ||
| Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults. | Q35850248 | ||
| Optimal management of allergic rhinitis | Q35888881 | ||
| Vehicular exhaust particles promote allergic airway inflammation through an aryl hydrocarbon receptor-notch signaling cascade | Q35931425 | ||
| Exposure to allergen and diesel exhaust particles potentiates secondary allergen-specific memory responses, promoting asthma susceptibility. | Q35931652 | ||
| Tregs and allergic disease | Q35951537 | ||
| Dendritic cell-mediated T cell polarization | Q35988802 | ||
| Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis | Q36228836 | ||
| Regulatory T-lymphocytes in asthma | Q36303565 | ||
| Morphometric analysis of inflammation in bronchial biopsies following exposure to inhaled diesel exhaust and allergen challenge in atopic subjects | Q36457620 | ||
| Environmental assessment and exposure control: a practice parameter--furry animals | Q36460235 | ||
| Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. | Q36507987 | ||
| Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: a novel tool for specific immunotherapy | Q36549691 | ||
| Allergic sensitization, rhinitis, and tobacco smoke exposure in U.S. children and adolescents. | Q36607899 | ||
| Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease | Q36838246 | ||
| Toxic and adjuvant effects of silica nanoparticles on ovalbumin-induced allergic airway inflammation in mice | Q36911253 | ||
| Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells | Q36950405 | ||
| Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice | Q37059794 | ||
| Exposure to airborne particulate matter is associated with methylation pattern in the asthma pathway | Q37156995 | ||
| Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization | Q37173058 | ||
| CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity | Q37284012 | ||
| Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. | Q50994741 | ||
| Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy. | Q51053285 | ||
| A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. | Q51543765 | ||
| Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals: a controlled human exposure study. | Q51573680 | ||
| Characterisation of particulate matter on airborne pollen grains. | Q51615775 | ||
| CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study. | Q51625277 | ||
| Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). | Q51673088 | ||
| Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. | Q51733008 | ||
| Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. | Q51811667 | ||
| Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. | Q51813678 | ||
| Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. | Q51819173 | ||
| Inflammatory health effects of indoor and outdoor particulate matter. | Q52362505 | ||
| Developing Anti-HER2 Vaccines: Breast Cancer Experience. | Q52564339 | ||
| Allergen immunotherapy: a practice parameter third update. | Q52712682 | ||
| A Jagged1-Notch4 Molecular Switch Mediates Airway Inflammation by Ultrafine Particles. | Q52720947 | ||
| Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy. | Q52725196 | ||
| Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines. | Q52767099 | ||
| TH2 cell development and function. | Q52862184 | ||
| Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite. | Q53084576 | ||
| Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. | Q53099848 | ||
| Ambient PM2.5 exposure exacerbates severity of allergic asthma in previously sensitized mice. | Q53178028 | ||
| Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice. | Q53333330 | ||
| Pulmonary exposure to carbon black nanoparticles increases the number of antigen-presenting cells in murine lung. | Q53492757 | ||
| Regulatory T cells in allergy and asthma. | Q53527505 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1334 | |
| P577 | publication date | 2020-06-30 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease | |
| P478 | volume | 11 |
| Q112210907 | The influence of exposure approaches to in vitro lung epithelial barrier models to assess engineered nanomaterial hazard | cites work | P2860 |
Search more.